GlassScriptPhysician profile
Benjamin Michael Julian Thompson
NPI 1669527362
$7,969.65
in general payments reported to CMS, 2019-2025
11 companies · $1,334 in 2025
The $1,334 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,217 · 2020: $1,666 · 2021: $25.97 · 2022: $187 · 2023: $14.56 · 2024: $524 · 2025: $1,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,081 · Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,080.54 |
| Food and Beverage | $792.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,804.26 | 2019-2025 | Blueprint Patient Specific Instrumentation, Axsos |
| Arthrex, INC. | $1,814.13 | 2019-2025 | |
| Kairos Surgical INC | $897.64 | 2020 | |
| Conformis, INC. | $680.83 | 2020 | |
| Smith+Nephew, INC. | $351.86 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Maverick |
| Catalyst Orthoscience | $120.07 | 2022 | |
| Pacira Therapeutics, INC. | $109.57 | 2019 | |
| Linvatec Corporation | $69.53 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $63.12 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $45.66 | 2020-2023 | Euflexxa |
| Bioventus LLC | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.